Low prevalence of hypopituitarism after subarachnoid haemorrhage using confirmatory testing and with BMI-specific GH cut-off levels

European Journal of Endocrinology

Volumn 168, Issue 4, 2013, Pages 473-481

  Gardner, Chris J ^a   Javadpour, Mohsen ^b   Stoneley, Catherine ^b   Purthuran, Mani ^b   Biswas, Shubhabrata ^b   Daousi, Christina ^a   MacFarlane, Ian A ^a   Cuthbertson, Daniel J ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCAGON; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; RECOMBINANT GLUCAGON; TETRACOSACTIDE;

ADENOHYPOPHYSIS DISEASE; ADRENAL CORTEX DISEASE; ADULT; ARTICLE; BODY MASS; BRAIN INFARCTION; COHORT ANALYSIS; CONTROLLED STUDY; ENDOCRINE FUNCTION TEST; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HYPOCORTISOLEMIA; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ADULT; AGED; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE;

EID: 84875206044     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0849     Document Type: Article

References (38)

1. Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavo S, Scaroni C, Fusco A, Del Monte P, De Menis E, Faustini-Fustini M et al. Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. Journal of Clinical Endocrinology and Metabolism 2005 90 6085-6092. (doi:10.1210/jc.2005-0504)
2. Dimopoulou I, Kouyialis AT, Tzanella M, Armaganidis A, Thalassinos N, Sakas DE & Tsagarakis S. High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage. Stroke 2004 35 2884-2889. (doi:10.1161/01.STR.0000147716.45571.45)
3. Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R & Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. Journal of Neurosurgery 2000 93 743-752. (doi:10.3171/jns.2000.93.5.0743)
4. Kreitschmann-Andermahr I. Subarachnoid hemorrhage as a cause of hypopituitarism. Pituitary 2005 8 219-225. (doi:10.1007/s11102-006-6044-2)
5. Tanriverdi F, Dagli AT, Karaca Z, Unluhizarci K, Selcuklu A, Casanueva FF & Kelestimur F. High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clinical Endocrinology 2007 67 931-937. (doi:10.1111/j.1365-2265.2007.02989.x)
6. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK & Agha A. Hypothalamo-pituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. Journal of the American Medical Association 2007 298 1429-1438. (doi:10.1001/jama.298.12.1429)
7. Klose M, Brennum J, Poulsgaard L, Kosteljanetz M, Wagner A & Feldt-Rasmussen U. Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage. Clinical Endocrinology 2010 73 95-101. (doi:10.1111/j.1365-2265. 2010.03791.x)
8. Lammert A, Bode H, Hammes HP, Birck R, Fatar M, Zohsel K, Schmieder K, Schubert GA, Thome C & Seiz M. Aneurysmal subarachnoid hemorrhage (aSAH) results in low prevalence of neuro-endocrine dysfunction and NOT deficiency. Pituitary 2011 15 505-512. (doi:10.1007/s11102-011-0357-5)
9. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML & Endocrine S. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2011 96 1587-1609. (doi:10.1210/jc.2011-0179)
10. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700. (doi:10.1530/EJE-07-0631)
11. Tzanela M, Zianni D, Bilariki K, Vezalis A, Gavalas N, Szabo A, Drimala P, Vassiliadi D & Vassilopoulos C. The effect of body mass index on the diagnosis of GH deficiency in patients at risk due to a pituitary insult. European Journal of Endocrinology 2009 162 29-35. (doi:10.1530/EJE-09-0390)
12. van der Schaaf I, Algra A,Wermer M, Molyneux A, Clarke M, van Gijn J & Rinkel G. Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews 2005 19 CD003085.
13. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L & Wiren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Quality of Life Research 1999 8 373-383. (doi:10.1023/A:1008987922774)
14. Teasedale GM, Drake CG, HuntW, Kassell N, Sano K, Pertuiset B & De Villiers JC. A universal subarachnoid haemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. Journal of Neurology, Neurosurgery, and Psychiatry 1988 51 1457. (doi:10.1136/jnnp.51.11.1457)
15. Fisher CM, Kistler JP & Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980 6 1-9. (doi:10.1227/00006123-198001000-00001)
16. Leong KS,Walker AB, Martin I,Wile D,Wilding J & MacFarlane IA. An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease. Clinical Endocrinology 2001 54 463-468. (doi:10.1046/j.1365-2265.2001.01169.x)
17. Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. European Journal of Endocrinology 2005 153 257-264. (doi:10.1530/eje.1.01967)
18. Littley MD, Gibson S, White A & Shalet SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects. Clinical Endocrinology 1989 31 527-533. (doi:10.1111/j.1365-2265.1989.tb01276.x)
19. Kokshoorn N, Wassenaar M, Biermasz N, Roelfsema F, Smit J, Romijn J & Pereira A. Hypopituitarism following traumatic brain injury: the prevalence is affected by the use of different dynamic tests and different normal values. European Journal of Endocrinology 2009 162 11-18. (doi:10.1530/EJE-09-0601)
20. Lissett CA, Thompson EG, Rahim A, Brennan BM & Shalet SM. How many tests are required to diagnose growth hormone (GH) deficiency in adults? Clinical Endocrinology 1999 51 551-557. (doi:10.1046/j.1365-2265.1999.00836.x)
21. Iranmanesh A, Lizarralde G & Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism 1991 73 1081-1088. (doi:10.1210/jcem-73-5-1081)
22. Kelestimur F, Popovic V, Leal A, Van Dam PS, Torres E, Perez Mendez LF, Greenman Y, Koppeschaar HP, Dieguez C & Casanueva FF. Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRHCGHRP-6 test. Clinical Endocrinology 2006 64 667-671. (doi:10.1111/j.1365- 2265.2006.02525.x)
23. Bonert VS, Elashoff JD, Barnett P & Melmed S. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 2004 89 3397-3401. (doi:10.1210/jc.2003-032213)
24. Cordido F, Alvarez-Castro P, Isidro ML, Casanueva FF & Dieguez C. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. European Journal of Endocrinology 2003 149 117-122. (doi:10.1530/eje.0.1490117)
25. Orme SM, Price A, Weetman AP & Ross RJ. Comparison of the diagnostic utility of the simplified and standard i.m. glucagon stimulation test (IMGST). Clinical Endocrinology 1998 49 773-778. (doi:10.1046/j.1365-2265.1998.00610.x)
26. Rao RH & Spathis GS. Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses. Metabolism 1987 36 658-663. (doi:10.1016/0026-0495(87)90150-8)
27. Conceicao FL, da Costa e Silva A, Leal Costa AJ & Vaisman M. Glucagon stimulation test for the diagnosis of GH deficiency in adults. Journal of Endocrinological Investigation 2003 26 1065-1070.
28. Toogood A. Growth hormone tests: are they all the same? Hormone Research 2007 68 (Suppl 5) 66-67. (doi:10.1159/000110479)
29. Yuen KC, Biller BM, Molitch ME & Cook DM. Clinical review: is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? Journal of Clinical Endocrinology and Metabolism 2009 94 2702-2707. (doi:10.1210/jc.2009- 0299)
30. Gomez JM, Espadero RM, Escobar-Jimenez F, Hawkins F, Pico A, Herrera-Pombo JL, Vilardell E, Duran A, Mesa J, Faure E et al. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clinical Endocrinology 2002 56 329-334. (doi:10.1046/j.1365-2265.2002. 01472.x)
31. Kreitschmann-Andermahr I, Hoff C, Saller B, Niggemeier S, Pruemper S, Hutter BO, Rohde V, Gressner A, Matern S & Gilsbach JM. Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage. Journal of Clinical Endocrinology and Metabolism 2004 89 4986-4992. (doi:10.1210/jc.2004-0146)
32. Bellebaum C, Schafers L, Schoch B, Wanke I, Stolke D, Forsting M & Daum I. Clipping versus coiling: neuropsychological follow up after aneurysmal subarachnoid haemorrhage (SAH). Journal of Clinical and Experimental Neuropsychology 2004 26 1081-1092. (doi:10.1080/13803390490515342)
33. Osterman PO. Hypothalamo-pituitary-adrenal function following subarachnoid hemorrhage. Acta Neurologica Scandinavica 1975 52 56-62. (doi:10.1111/j.1600-0404.1975.tb02827.x)
34. Veldhuis JD, Iranmanesh A, Roelfsema F, Aoun P, Takahashi P, Miles JM & Keenan DM. Tripartite control of dynamic ACTH- cortisol dose responsiveness by age, body mass index, and gender in 111 healthy adults. Journal of Clinical Endocrinology and Metabolism 2011 96 2874-2881. (doi:10.1210/jc.2011-0084)
35. Crompton MR. Hypothalamic lesions following the rupture of cerebral berry aneurysms. Brain 1963 86 301-314. (doi:10.1093/brain/86.2.301)
36. Bjerre P, Videbaek H & Lindholm J. Subarachnoid hemorrhage with normal cerebral angiography: a prospective study on sellar abnormalities and pituitary function. Neurosurgery 1986 19 1012-1015. (doi:10.1227/00006123- 198612000-00018)
37. Karaca Z, Tanriverdi F, Dagli AT, Selcuklu A, Casanueva FF, Unluhizarci K & Kelestimur F. Three years prospective investigation of pituitary functions following subarachnoid haemorrhage. Pituitary, 2013. In press. (doi:10.1007/s11102-012-0377-9)
38. Gardner CJ, Javadpour M, Morgan C, Daousi C, Macfarlane IA & Cuthbertson DJ. Hypopituitarism - a late consequence of aneurysmal subarachnoid haemorrhage? British Journal of Neurosurgery 2011 25 337-338. (doi:10.3109/02688697.2010.546900)